SAN JOSE, Calif., May 9 /PRNewswire-FirstCall/ -- Human Pheromone Sciences, Inc. (OTC:EROX) (BULLETIN BOARD: EROX) ("HPS" or "the Company") today announced the signing of a License Agreement with Schwarzkopf & Henkel, a Division of Henkel Consumer Goods, Inc. Under the terms of the Agreement, HPS granted the Licensee a non-exclusive worldwide license to certain HPS patents in exchange for an initial cash payment and future royalties on sales of Schwarzkopf & Henkel's got2b magnetik(R) hair care products. "We are looking forward to working with Schwarzkopf & Henkel as they look to expand the use of the Company's patented technology in the very exciting hair care market," a spokesperson for HPS indicated. The Company confirmed that it continues to test additional types of mood-enhancing compounds that have shown significant promise in human testing, and will seek partners to bring these new compounds to market, as well as continue to expand the use of its currently patented compounds. Human Pheromone Sciences, Inc. is a technology-based company, whose proof- of concept products included prestige-priced fragrances and toiletries and environmental products sold under the Natural Attraction(R), REALM(R), innerREALM(R) and EROX(R) trademarks. These products contain mood-enhancing compounds, whose efficacy has been validated at leading universities around the world, and whose use is covered under United States and foreign patents. The Company is also involved in research and product development efforts on new compounds that have been previously identified as stimulating the emotional centers of the human brain. Further information is available on line at http://www.erox.com/. The statements in this news release may contain forward-looking statements that involve risks and uncertainties that could cause results to differ from predicted results. Further information on factors that could affect the Company's results is detailed in the Company's annual report to shareholders on Form 10-KSB for the year ended December 31, 2006, as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. DATASOURCE: Human Pheromone Sciences, Inc. CONTACT: William P. Horgan, Chairman, CEO of Human Pheromone Sciences, Inc., +1-408-938-3030 Web site: http://www.erox.com/

Copyright